Target
Beta-lactamase
Ligand
BDBM361144
Substrate
n/a
IC50
0.053±n/a nM
Citation
 Bennett, FJiang, JPasternak, ADong, SGu, XScott, JDTang, HZhao, ZHuang, YYang, DYoung, KXiao, LZhang, ZFu, J Metallo-beta-lactamase inhibitors US Patent  US10544130 Publication Date 1/28/2020 
Target
Name:
Beta-lactamase
Synonyms:
n/a
Type:
Protein
Mol. Mass.:
29508.45
Organism:
n/a
Description:
Q2QC95
Residue:
266
Sequence:
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
 
Inhibitor
Name:
BDBM361144
Synonyms:
(R)-4-(1H- benzo[d]imidazol-4-yl)- N1-(3-amino-2- hydroxypropyl)-3-(2H- tetrazol-5-yl)-benzene-1,2- disulfonamide | US10221163, Example 301 | US10544130, Example 301
Type:
Small organic molecule
Emp. Form.:
C17H19N9O5S2
Mol. Mass.:
493.52
SMILES:
NC[C@@H](O)CNS(=O)(=O)c1ccc(-c2cccc3[nH]cnc23)c(-c2nn[nH]n2)c1S(N)(=O)=O |r|
Structure:
Search PDB for entries with ligand similarity: